The small GTP-binding Rho proteins control a variety of biological activities, including organization of the actin cytoskeleton, regulation of gene expression and cellular transformation. In contrast, Ras proteins do not induce actin stress ®bers, but potently transform cells which exhibit a morphology clearly distinct from that caused by activated forms of Rho. To investigate whether nuclear signaling and oncogenic potential of Rho are a consequence of its profound eect on cytoskeletal organization, we replaced each amino acid in the Rho eector loop with those of Ras, or replaced conserved residues with others known to result in dierential signaling capability when introduced into Ras and Rac1. These Rho mutants did not gain the ability to induce the MAPK, JNK or p38 pathways but, surprisingly, all Rho eector loop mutants still continued to induce actin stress ®ber formation. However, three of these Rho mutants, with substitutions of leucine-39, glutamic acid-39, or cysteine-42, lost the ability to stimulate gene transcription via the serum response factor (SRF) and failed to induce neoplastic transformation. Thus, these results indicate that cytoskeletal changes are not sucient to induce the transformed phenotype, and that Rho-eector molecules regulating the actin cytostructure are distinct from those signaling to the nucleus and subverting normal growth control.
Introduction
The Rho family of proteins comprises a large branch within the Ras superfamily of small GTP binding proteins. Cycling between an active GTP-bound form and an inactive GDP-bound form, the Rho protein can integrate extracellular signals to speci®c targets regulating cell morphology, cell aggregation, tissue polarity, cytokinesis, cell motility and smooth muscle contraction (Hotchin and Hall, 1996; . Rho's activity is modulated by speci®c guaninenucleotide exchange factors (GEFs) and GTPase activating proteins (GAPs) , that provide a ®ne tuning to the state of Rho activation (Boguski and McCormick, 1993; Nobes and Hall, 1994) . In turn, GTP-bound forms of Rho dramatically aect the organization of the cellular actin cytoskeleton. For example, when microinjected into Swiss 3T3 fibroblasts, activated Rho rapidly induces the formation of actin stress ®bers and focal contacts (Ridley and Hall, 1992) .
Ras proteins, on the other hand, are essential components in the biochemical pathways transducing proliferative signals from the vast majority of growth factor receptors (Schlessinger, 1993) . At the molecular level, the function of Ras is to regulate the activity of a cascade of serine-threonine kinases leading to the activation of mitogen activated kinases (MAP kinases) which, in turn, control the activity of nuclear transcription factors that are critical for cell growth (Davis, 1993; Macara et al., 1996; Seger and Krebs, 1995) . However, recent work has established that the protein product of certain oncogenes, including dbl, vav, ost, lfc and lbc, do not aect Ras function, but instead they act as GEFs for Rho proteins (Boguski and McCormick, 1993; . Furthermore, Rho proteins have been shown to be an essential component of the Ras transforming pathway Olson et al., 1995; Prendergast et al., 1995; Qiu et al., 1995a, b) , and activated forms of Rho proteins have been shown to harbor transforming potential (Perona et al., 1993; Self et al., 1993) , together suggesting that Rho also plays a role in cell growth control and oncogenesis.
Recently available evidence suggest that Rho proteins are also integral components of signaling pathways leading to transcriptional control. For example, Rac and Cdc42, two members of the Rho family of small GTP-binding proteins, have been reported to activate the c-Jun amino-terminal kinase (JNK) thereby regulating the transcriptional activity of c-Jun (Coso et al., 1995; Minden et al., 1995) , and Rho has been recently shown to induce expression from the serum responsive element (SRE) through the transcriptional activation of the serum response factor (SRF) (Hill et al., 1995) . Still, there remains a gap in our understanding of the biochemical pathways utilized by Rho to induce these multiple eects. In particular, whether the nuclear signaling and oncogenic potential of Rho are a consequence of its profound eects on the cytoskeletal organization is still unknown. Prior studies using chimeras and mutational analysis have de®ned the eector domain for the GTPases Rac and Ras, and demonstrated that these proteins can activate multiple molecular targets, thus leading to speci®c biological responses (Joneson et al., 1996a, b; Khosravi-Far et al., 1996; Lamarche et al., 1996; Westwick et al., 1997; White et al., 1995) . In this study, we have engineered a number of RhoA eector domain mutants, and used them to explore the nature of the transforming pathway utilized by GTPases of the Rho family.
Results
The biological and biochemical eects of Rho and Ras are clearly distinguishable: activated Ras (Ras V12) fails to induce actin stress ®bers but greatly activates MAPK and, to a limited extent, JNK and SRFmediated transcription from the SRE. However, activated RhoA (RhoA QL) does not stimulate MAPK or JNK activity, but potently activates SRF and induces actin stress ®ber formation (Figure 1a) . Furthermore, when expressed in rodent ®broblasts, Ras V12 and RhoA QL proteins induce foci of transformation with clearly distinct morphologies. Thus, we reasoned that if the morphological, nuclear signaling and transforming pathways are dierentially regulated by these small GTP-binding proteins, we might be able to identify mutations in Rho selectively aecting these activities. To that end, we introduced point mutations into the eector domain of the activated form of human RhoA, RhoA QL, by replacing each amino acid with the corresponding Ras residue (D28N, V33E, V35D, F39E, A44K, D45Q, E47V), or by substituting conserved residues for amino acids known to result in dierential signaling capabilities when introduced into Ras or Rac1 (T37S, F39L and Y42C) (Joneson et al., 1996a, b; Khosravi-Far et al., 1996; Westwick et al., 1997; White et al., 1995) . The resulting DNA constructs harboring point mutations were characterized for both expression and ability of the corresponding protein products to remain in the activated GTPbound state. As shown in Figure 1B , expression of each mutated GST-fusion RhoA QL protein in COS-7 cells was readily demonstrable upon anity purification with glutathione-agarose. All of the Rho mutants were also in the GTP-bound form, as judged by their ability to bind in vivo labeled guanine nucleotides, which was similar in all cases to that of the Rho A QL activated protein ( Figure 1B) .
These mutated Rho proteins were studied for their ability to stimulate three independent MAPK pathways, MAPK, JNK, and p38, upon coexpression in COS-7 cells with epitope-tagged forms of these extracellular regulated kinases. As shown in Figure 2 , when expressed in COS-7 cells, Ras clearly activated an epitope-tagged MAPK and slightly an epitope-tagged JNK, without aecting the enzymatic activity of an (Coso et al., 1995; Zhang et al., 1995) , actin stress ®ber formation (Ridley et al., 1995; Ridley. and Hall, 1992) and SRF activaton (Hill et al., 1995) :+++indicates a strong response,+a weak response and 7 no detectable response. (B). Protein expression and activation state of RhoA, RhoA QL and RhoA QL eector domain mutants. (a) COS-7 cells were transfected with pCEFL-GST expression plasmid containing RhoA, RhoA QL, RhoA QL eector domain mutants or no insert (GST). Protein expression was con®rmed by anity puri®cation with glutathione-agarose followed by protein immunoblot analysis with antibodies to GST. (b) Analysis of guanine nucleotides bound to small GTPases was performed. All RhoA QL mutations were in an activated GTPbound state. Ori, GTP and GDP depict the origin of the chromatography and the mobility of unlabeled GDP and GTP, respectively epitope-tagged p38, as judged by in vitro immunocomplex kinase reactions, as previously reported (Coso et al., 1995; Zhang et al., 1995) . Rho and its mutants, however, failed to stimulate any of these kinases (Figure 2 ), thus indicating that the introduction in RhoA of single point mutations to resemble the Raseector domain did not result in the gain of Ras functions.
To investigate the eects of the mutational substitutions in RhoA in their ability to induce stress ®ber formation, Madine ± Darby canine kidney (MDCK) cells were transfected with each of the Rho mutants and studied for their changes in cytoskeletal organization. Using AU5-tagged mutants, the MDCK cells were examined by¯uorescence microscopy to determine the eect of each protein, which was detected by indirect immuno¯uorescence employing an anti-AU5 antibody, and with rhodamine conjugated phalloidin to directly identify the ®lamentous actin containing structures. As shown in Figure 3 , the subcellular distributions of Ras and Rho proteins appeared to be identical and under these conditions, serum starved MDCK cells which were negative for RhoA or its mutants exhibited very low levels of stress ®bers. In contrast, RhoA QL overexpression induced the formation of multiple actin stress ®bers and enhanced overall staining for F-actin associated with a contracted cellular morphology, clearly distinguishing transfected cells from adjacent cells. Ras, on the other hand, did not induce actin stress ®ber formation. Unexpectedly, under identical experimental conditions all of the RhoA QL eector mutants induced actin polymerization and actin micro®lament bundle formation to the same extent as that seen for activated RhoA (Figure 3 ). Similar massive actin stress ®bers were also observed in primary human ®broblasts transiently transfected with RhoA QL and RhoA mutants (data not shown). Thus, none of the ten Rho eector mutants tested lost their ability to activate downstream molecules controlling actin stress ®ber formation.
Recently, Rho proteins have been shown to signal to the SRE through a pathway aecting the transcriptional activity of SRF, independent of any MAPK described to date (Hill et al., 1995) . Because Rho mutants were still able to induce actin cytoskeletal reorganization, we next explored whether Rho mutants also retained their ability to signal to the SRE. To that end, NIH3T3 cells were transfected with the RhoA QL mutants along with a reporter plasmid containing the wild-type SRE sequence (SREwt CAT) or a mutated SRE reporter which eliminated the ternary complex Figure 2 Activation of MAP Kinase pathways by the small GTP-binding proteins RhoA QL, Ras V12, and RhoA QL mutants. COS-7 cells were transfected with pCEFL vector (control) or with the same expression vector carrying cDNAs for wild type RhoA or activated forms of Ras, RhoA or RhoA QL eector domain mutants together with epitope-tagged forms of MAPK, JNK or p38 as indicated (1 mg per plate in each case) and subjected to in vitro kinase. Western blot analyses were performed on anti-HA immunoprecipitates from the corresponding cellular lysates and immunodetected with MAPK, JNK or p38 antisera (not shown). Anisomycin (10 mg/ml) stimulation served as a positive control for JNK and p38 assays. Positions of the labeled substrates MBP and ATF2(96) are indicated Figure 3 Actin reorganization induced by H-RasV12, RhoA QL and RhoA QL eector domain mutants. MDCK cells were transfected with AU5-tagged expression plasmid pCEFL encoding Ras V12, wild type RhoA, activated RhoA QL or RhoA eector mutants. Cells were ®xed and stained after 48 h with rhodamine labeled phalloidin to evaluate actin micro®lament formation. All Rho mutations were tested, and showed a similar extent of actin reorganization (Figure 3 and data not shown). Expression of each small G protein was con®rmed by immunostaining using an anti-AU5 monoclonal antibody. Similar results were obtained for each experimental plasmid in 3 ± 5 independent experiments
Transforming and cytoskeletal pathways induced by Rho A M Zohar et al factor (TCF) binding site (SREmutL CAT) (Hill et al., 1995) . As shown in Figure 4 , when used as a control, RasV12 activated the SREwt but not the SREmutL construct, further supporting the concept that Ras acts on the SRE via a TCF dependent mechanism. In contrast, RhoA QL potently induced activity of both reporter systems ( Figure 4A and B) . Interestingly, however, RhoA QL F39L induced SRE less eciently, and two of the ten mutations, RhoA QL F39E and Y42C, failed to stimulate the SRE or SREmutL, showing little or no increase in CAT activity in either assay ( Figure 4A and B) . These data strongly suggest that the signaling pathway(s) connecting Rho to the nucleus are dierent from those regulating the actin cytoskeleton.
When expressed in NIH3T3 cells, activated forms of Rho can induce the constitutive activation of proliferative pathways leading to malignant transformation (Ridley, 1996; Symons, 1996) . To test whether this biological activity of Rho was due to its eect on cytoskeletal structures or required its ability to induce transcriptional activation, we conducted focus-formation assays with the various Rho mutants. When transfected into these cells, each expression plasmid produced similar numbers of G418-resistant colonies (data not shown), indicating similar transfection eciencies. As shown in Figure 5A , foci induced by Rho and Ras exhibited a readily distinguishable morphology. Rho-induced foci appeared more compact and well delineated as opposed to the more amorphous and diuse phenotype induced by Ras.
Similar Rho-like foci were induced upon expression of the majority of the Rho eector domain mutants. However, RhoA QL F39L and RhoA QL F39E and Y42C, which induced SRE less eciently or had lost the ability to induce the SRE, respectively, completely lost their focus-forming ability ( Figure 5B ). Quantitation of the focus-forming activity (Table 1) indicated that all RhoA mutations other than the 39 and 42 residue mutants, were similar to RhoA QL in their ability to induce foci. Thus, the potential to induce neoplastic transformation did not correlate with the induction of cytoskeletal reorganization, but instead correlated with the ability of the Rho proteins to drive transcriptional activity.
To characterize further the transforming capability of the various Rho mutants, we tested the ability of NIH3T3 transfectants to form tumors in vivo in nude mice. For these analyses, we utilized pooled mass cultures of neomycin-resistant NIH3T3 cells stably expressing RasV12 or each Rho mutant. We observed that cells transfected with RasV12, RhoA QL and seven of the RhoA QL mutations formed large tumors 3 weeks post-injection. In contrast, the three mutants, RhoA QL F39E, F39L and Y42C that did not harbor focus-forming ability also did not induce tumors during the 12 weeks of observation (Table 1) . Thus, we conclude that the RhoA eector mutants, F39E, F39L and Y42C, have lost their oncogenic potential in spite of eectively aecting cytoskeletal structures.
Discussion
Studies using eector domain mutants have been central for deciphering the complex nature of the transforming pathways utilized by Ras and Rac1 and the involvement of speci®c downstream eector molecules (Joneson et al., 1996a, b; Khosravi-Far et al., 1996; Lamarche et al., 1996; Westwick et al., 1997; White et al., 1995) . Interestingly, the oncogenic potential of Rac1 correlated with its ability to induce morphological changes (Lamarche et al., 1996) , thus suggesting that cytoskeletal reorganization may be a critical component of cell transformation. In this regard, how the reorganization of the cellular actin cytoskeleton aects gene expression ultimately leading to cancerous growth is still poorly understood. In other studies, stimulation of DNA synthesis by Ras eector mutants correlated primarily with their ability to activate the MAPK signaling pathway rather than with cytoskeletal changes (Joneson et al., 1996b) . In this study, we introduced point mutations in the eector domain of RhoA, and were able to dissociate cell transformation and nuclear signaling from the cytoskeletal eects of Rho. All mutations in the Rhoeector domain were able to induce actin stress ®bers, yet replacing two highly conserved residues within the Rho family, F39 and Y42, resulted in Rho proteins that although retained strong actin stress ®ber induction, they were impaired in their ability to activate SRE-transcription as well as transformation. This clearly indicates that regulation of gene expression by Rho is not required for induction of stress ®bers and that transcriptional activation by Rho proteins is not a consequence of their eects on the actin cytostructure. One of the Rho eector mutants, RhoA QL F39L, was still able to induce signi®cant expression from an SRE-regulated reporter plasmid, but this mutation abolished completely its transforming potential. Consonant with this observation, others have recently observed that Rho proteins de®cient in their ability to associate with the plasma membrane can nevertheless stimulate SRE-driven transcription but fail to induce focus formation (Lebowitz et al., 1997) . In addition, SRE activation did not correlate with the ability of Rac eector mutants to induce foci formation (Westwick et al., 1997) . Thus, these data suggest that the RhoA QL F39L eector mutant may be useful to dissect downstream biochemical routes involved in nuclear signaling from those involved in cellular transformation. Taken together, it appears that SRE activation is not sucient to induce cellular transformation, yet, whether it is necessary remains to be elucidated.
Much progress has been made over the past few years towards the identi®cation of the downstream target molecules of Rho. To date, a number of Rhointeracting proteins have been identi®ed: three serinethreonine kinases, protein kinase N (PKN), p160 ROCK and ROK; several structural proteins, including rhophilin, rhotekin, citron, and the murine homolog of Drosophila diaphanous; and enzymes aecting lipid mediators, such as phosphatidylinositol 4-phosphate 5-kinase (PIP 5-kinase) (Amano et al., 1996; Madaule et al., 1995; Nakagawa et al., 1996; Narumiya et al., 1997; Reid et al., 1996; . The majority of these molecules are believed to play roles in actin polymerization, although ROK was recently shown to induce SRE activation (Chihara et al., 1997) . Thus, the redundancy of molecules mediating the cytoskeletal changes induced by Rho, and recently available evidence suggesting that a region carboxyl-terminal to the Rho eector loop is also involved in promoting cytoskeletal reorganization (Diekmann et al., 1995) , might help explain why single point mutants in the Rho eector loop are still capable of potently inducing stress ®ber formation even though defective in other functions.
Our results suggest that actin stress ®ber formation and nuclear signaling and cellular transformation induced by Rho can be mutationally separated. Indeed, eector domain mutants that failed to induce SRF-dependent transcription and cellular transformation were, nevertheless, able to induce stress ®ber formation to an extent comparable to that caused by activated Rho, thus indicating that Rho-induced cytoskeletal reorganization is not sucient to signal to the nucleus nor to induce malignant transformation. Taken together, these ®ndings raise the possibility of the existence of multiple independent eector pathways dictating Rho functions: a biochemical route promoting cytoskeletal remodeling, likely to involve the majority of the Rho-binding proteins described to date, and other(s) controlling nuclear signaling and cellular transformation. We can conclude that our present study dissociates nuclear signaling and malignant transformation from the characteristic eects of Rho on the cytoskeleton; this provides the foundation for identifying key growth promoting molecules involved in the transforming pathway elicited by Rho.
Materials and methods

DNA constructs
Plasmids expressing epitope-tagged MAPK, JNK and p38 kinase, pcDNA3 HA-MAPK, pcDNA3 HA-JNK and pcDNA3 HA-p38 kinase, respectively were described previously (Coso et al., 1995) . Mutations were introduced into pGEX RhoA QL by PCR (QuikChange TM mutagenesis kit (Stratagene) according to the manufacturer's instuctions, subcloned into the BamHI-EcoRI sites of pCEFL-GST and pCEF-AU5 expression vectors (Teramoto et al., 1996) and sequenced. Sequence of the mutagenizing oligonucleotides will be made available upon request.
Western blots
Lysates containing approximately 50 mg of total cellular protein or anti-HA (12CA5, Babco) immunoprecipitates, or proteins bound to glutathione-sepharose beads, (Pharmacia) were analysed by Western blotting after SDS-polyacrylamide gel electrophoresis as described previously (Teramoto et al., 1996) . Immunocomplexes were visualized by enhanced chemiluminescence detection (Amersham Corp.) using goat anti-mouse or goat antirabbit IgGs coupled to horseradish peroxidase as secondary antibody (Cappel).
Guanine nucleotide assay
COS-7 cells were transfected by the DEAE-dextran method, adjusting the total amount of DNA to 5 ± 10 mg/ plate with vector alone. After 48 h, cells were labeled with 0.05 mCi per ml of 32 P-orthophosphate for 4 h in DMEM Figure 5a .
b Animals bearing tumors greater than 20 mm during a 35 day observation period were sacri®ced. c Relative SRE activation as determined in Figure 4 . d Actin stress ®ber induction as determined in Figure 3 Transforming and cytoskeletal pathways induced by Rho A M Zohar et al phosphate-free medium, and then lysed in a buer containing 50 mM Tris-HCl, pH 7.5, 20 mM MgCl 2 , 150 mM NaCl, 0.5% NP40, 1 mM Na 3 VO 4 , 25 mg/ml leupeptin, 25 mg/ml aprotinin and 1 mM phenylmethylsulfonyl¯uoride. Each small GTP-binding protein was anity-puri®ed by binding to glutathione-agarose beads. Beads were then washed and bound nucleotides were released and analysed by polyethyleneimine thin layer chromatography as described (Teramoto et al., 1996) .
Kinase assays
COS-7 cells were transfected by the DEAE-dextran method, adjusting the total amount of DNA to 5 ± 10 mg/ plate with vector alone. MAPK, JNK and p38 activity in cells transfected with an epitope-tagged MAPK (HA-ERK2, referred to as HA-MAPK), and epitope-tagged JNK (HA-JNK) and p38 (HA-p38) was determined as previously described (Coso et al., 1995) using myelin basic protein (Sigma) or puri®ed, bacterially-expressed GST-ATF2(96) as substrates, respectively. Samples were analysed by SDS-gel electrophoresis on 12% acrylamide gels. Parallel lysates of cells transfected with the HA-MAPK, HA-JNK and HA-p38 expression plasmids were immunoprecipitated with anti-HA antibody and processed for Western blot analysis using an ERK2, JNK1 or p38 speci®c antiserum (Santa Cruz), respectively.
Indirect immuno¯uorescence
MDCK cells were transfected by the calcium-phosphate precipitation technique. Serum-starved transfected MDCK cells were washed twice with PBS then ®xed with 4% formaldehyde with 5% sucrose in PBS for 10 min and permeabilized with 0.5% Triton X-100 in PBS for 10 min. The cells were incubated with anti-AU5 mAb (Babco, Berkeley, CA) at 10 mg/ml for 1 h, washed three times with PBS and then incubated with a 1 : 100 dilution of uorescein-conjugated goat F(ab') 2 IgG anti-mouse (Biosource International, Camarillo, CA) and rhodamineconjugated phalloidin (Molecular Probes, Eugene, OR).
Coverslips were mounted in Gel-mount (Biomeda Corp., Foster City, CA) containing p-phenylenediamine (ICN) at 1 mg/ml to inhibit photobleaching and viewed using a Zeiss Axiophot photomicroscope equipped with epifluorescence. Immuno¯uorescence was photographed using Kodak TMAX 3200 ®lm.
Reporter gene assays
NIH3T3 cells were transfected with dierent expression plasmids together with 1 mg of pcDNA3-bgal, a plasmid expressing the enzyme b-galactosidase, and 1 mg of each of the reporter plasmids. After overnight incubation, the cells were maintained for 24 h in DMEM supplemented with 0.5% fetal bovine serum and then lysed using reporter lysis buer (Promega). Chloramphenicol acetyl transferase (CAT) activity was assayed in the cell extracts by incubation for 6 ± 16 h in the presence of 0.25 mCi [ 14 C]chloramphenicol (100 mCi/mmol) and 200 mg/ml butyryl-CoA in 0.25 M Tris-HCl, pH 7.4. Labeled butyrylated products were extracted using a mixture of xylenes (Aldrich) and counted.
Transfection of NIH3T3 cells and tumorigenesis in nude mice
Plasmid DNA transfection of NIH3T3 cells was performed by the calcium phosphate precipitation technique, and transformed foci were scored after 2 ± 3 weeks as described (Xu et al., 1993) . Mass populations expressing transfected genes were selected for their ability to grow in the presence of Geneticin (G418) (GIBCO). For tumorigenicity, 10 5 G418 selected cells (0.5 ml) were injected subcutaneously into 4 ± 8 week old female athymic NIH mice (nu/nu), and animals were examined twice per week for tumor formation.
